Surgeons complete microsurgery with 'robot hands'

Surgeons from Maastricht University Medical Center have successfully completed the first super-microsurgical procedure using 'robot hands.'

Covered in a presentation at the 26th World Congress of Lymphology in Barcelona, plastic surgeons using a robotic device created by Microsure were able to suture vessels 0.3 to 0.8 millimeters in size. The procedure was on a patient suffering from lymphedema, a chronic condition of fluid buildup.

Currently, the most effective treatment for lymphedema is the microsurgery that connects lymphatic vessels to blood vessels in order to restore the flow of fluid and reduce swelling. However, only a handful of surgeons around the globe are able to complete the difficult procedure due to its need for extreme precision.

Using the Microsure robot, surgeons' hand movements are converted into smaller and more precise movements completed by 'robot hands.' Accompanied by the ability to stabilize any tremors of the surgeons’ hand, the robot improves surgical outcomes by making the procedure more controlled and easier to complete.

"We are very pleased and proud that the first intervention using our robot has been a success, and that the surgeons are enthusiastic," said Raimondo Cau, developer of Microsure. "This proves that our technology is a key breakthrough in improving surgical care. As a next step, we aim to assist surgeons during other types of complex microsurgical procedures like tissue reconstructions after removal of a tumor. Using our device they will be able to perform surgery with better precision and fewer complications."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”